What is BioLife Solutions's less than 12 months?

BioLife Solutions (BLFS) reported less than 12 months of $57.93M in Q1 2026.

How has BioLife Solutions's less than 12 months changed year-over-year?

BioLife Solutions's less than 12 months increased by 479.6% year-over-year, from $10M to $57.93M.

BioLife Solutions BLFS Less than 12 months

Other financials

Income statement

See full

Revenue$27.5M+24.7%

Gross profit$17.5M+18.2%

Operating income$27.0K+105%

Net income$1.2M+365%

EPS (diluted)$0.02—

Balance sheet

See full

Cash & equivalents$22.8M-65.9%

Total debt$17.4M-35.6%

Total equity$372.2M+5.6%

Total assets$400.9M+1.5%

Cash flow

See full

Operating cash flow-$491.0K-128%

CapEx$167.0K-4.6%

Free cash flow-$658.0K-142%

Valuation

See full

Market cap$1.34B+33.1%

Enterprise value$1.34B+38.1%

P/S13.5×+0.6×

Profitability

See full

Gross margin66.9%—

Operating margin-16.7%—

Net margin-68.7%—

FCF margin-15.9%+18.7pp

Returns & leverage

See full

Return on equity-14.5%-4.7pp

Debt / equity0×0.0×

Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's less than 12 months.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioLife Solutions's less than 12 months?: BioLife Solutions (BLFS) reported less than 12 months of $57.93M in Q1 2026.
How has BioLife Solutions's less than 12 months changed year-over-year?: BioLife Solutions's less than 12 months increased by 479.6% year-over-year, from $10M to $57.93M.